Impacting Treatment Experience – Through the Optics of the Patient
Critical stakeholders in the trials ecosystem mainly sponsors and regulators want to see more than just test results and metrics when reviewing treatments. Criteria such as delayed disease progression and absence of side effects are impressive measures; however, they do not give a clear overview of the patient’s experience. Only a patient understands the impact […]
Impacting Treatment Experience – Through the Optics of the Patient Read More »









